Thiophene, 2-ethyl-5-(2-methylpropyl)-

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: Thiophene, 2-ethyl-5-(2-methylpropyl)-
• 英文别名: 2-ethyl-5-(2-methylpropyl)thiophene
• 化学式: C₁₀H₁₆S
• 分子量: 168.3
• InChiKey: AOXIFWAERABLJY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
  申请人：Yoshida Tomohiro

  公开号：US20100228026A1

  公开（公告）日：2010-09-09

  The invention provides a sulfonyl malonamide derivative, or a pharmacologically acceptable salt thereof or a solvate thereof, that has therapeutic and/or preventive effect(s) on various diseases due to its agonist action at AT 2 receptor, and is useful as a pharmaceutical agent for the treatment and/or prevention of diseases involving the renin-angiotensin-aldosterone system (RAAS).

  该发明提供了一种磺酰基马隆酰胺衍生物，或其药理学上可接受的盐或溶剂，由于其在AT2受体上的激动剂作用，对各种疾病具有治疗和/或预防作用，并且作为用于治疗和/或预防涉及肾素-血管紧张素-醛固酮系统（RAAS）疾病的药物剂形具有用处。
• VIRAL POLYMERASE INHIBITORS
  申请人：STAMMERS Timothy

  公开号：US20110230465A1

  公开（公告）日：2011-09-22

  Compounds of formula I: wherein X, R 2 , R 3 , R 5 and R 6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.

  式I的化合物：其中X、R2、R3、R5和R6的定义如本文所述，可用作丙型肝炎病毒NS5B聚合酶的抑制剂。
• ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES
  申请人：RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY

  公开号：US20160263083A1

  公开（公告）日：2016-09-15

  The invention provides compounds of formula Ia, Ib and Ic: and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

  本发明提供了Ia、Ib和Ic式化合物及其盐，其中变量如规范所述，以及包含Ia-Ic式化合物的组合物、制备这种化合物的方法以及使用这种化合物的方法，例如作为细菌RNA聚合酶的抑制剂和抗菌剂。
• 2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP0303269A2

  公开（公告）日：1989-02-15

  Disclosed is an anti-cancer compound of the formula wherein one of R¹ and R² is an optionally substituted furanyl-lower alkyl or thienyl-lower alkyl group; and the other of R¹ and R² is (i) lower alkanoyl having 1 or 2 substituents selected from a group -NR³R⁴ (wherein R³ and R⁴ each represent hydrogen, lower alkyl, lower alkoxy carbonyl or phenyl-lower alkoxycarbonyl), carboxyl, lower alkylthio, phenyl having hydroxyl or phenyl-lower alkoxy on the phenyl ring and phenyl-lower alkoxycarbonyl, or (ii) a pyrrolidinylcarbonyl optionally having lower alkoxycarbonyl, or a salt thereof.

  公开了一种抗癌化合物，其式如下 其中 R¹ 和 R² 之一是任选取代的呋喃低级烷基或噻吩低级烷基；其中 R³ 和 R⁴ 各自代表氢、低级烷基、低级烷氧基羰基或苯基-低级烷氧基羰基、羧基、低级烷硫基、苯基环上有羟基或苯基低级烷氧基的苯基和苯基低级烷氧基羰基，或 (ii) 可选择具有低级烷氧基羰基的吡咯烷基羰基或其盐。
• Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
  申请人：Shy Therapeutics LLC

  公开号：US11026930B1

  公开（公告）日：2021-06-08

  Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.

  本文提供了通过化合物与 Ras 超家族蛋白（在某些情况下包括 K-Ras 及其突变体）的 GTP 结合结构域结合，治疗涉及 Ras 超家族信号异常的癌症、炎症性疾病、rasopathies 和纤维化疾病的方法和组合物，以及检测此类组合物的新方法。